Search for other papers by Tristan Avril in
Google Scholar
PubMed
Search for other papers by Quentin Hennocq in
Google Scholar
PubMed
Search for other papers by Anne-Sophie Lambert in
Google Scholar
PubMed
Université Paris Cité, Faculté de Santé, UFR de Médecine, Paris, France
Search for other papers by Juliane Leger in
Google Scholar
PubMed
Search for other papers by Dominique Simon in
Google Scholar
PubMed
Université Paris Cité, Faculté de Santé, UFR de Médecine, Paris, France
Inserm UMR1185, Le Kremlin Bicetre, Paris, France
Search for other papers by Laetitia Martinerie in
Google Scholar
PubMed
Inserm UMR1185, Le Kremlin Bicetre, Paris, France
Paris-Saclay University, Paris, France
Search for other papers by Claire Bouvattier in
Google Scholar
PubMed
been obtained for all patients. Treatment modalities Pump group: Recombinant gonadotropins were administered continuously using a Paradigm insulin pump (Minimed, Northridge, CA, USA) along with a subcutaneous catheter (quick set 6 mm, 60 cm
Search for other papers by Lian Hollander-Cohen in
Google Scholar
PubMed
Search for other papers by Benjamin Böhm in
Google Scholar
PubMed
Search for other papers by Krist Hausken in
Google Scholar
PubMed
Search for other papers by Berta Levavi-Sivan in
Google Scholar
PubMed
performed in triplicate. Recombinant gonadotropins used in this study Recombinant LH and FSH from tilapia ( 20 , 21 ), sturgeon ( Acipenser gueldenstaedtii ) ( 22 ), and carp ( 9 ) were produced as biologically active, single-chain polypeptides in